CARILLON TOWER ADVISERS, INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$31,588,011,000
-20.3%
344,7720.0%0.31%
+17.0%
Q4 2019$39,614,303,000
+73945.4%
344,772
-18.7%
0.26%
-29.0%
Q3 2019$53,500,000
+4.8%
424,1330.0%0.37%
+6.3%
Q2 2019$51,040,000
+37.6%
424,1330.0%0.35%
+33.5%
Q1 2019$37,103,000
-12.6%
424,1330.0%0.26%
-26.7%
Q4 2018$42,434,000
-12.7%
424,1330.0%0.36%
+3.2%
Q3 2018$48,597,000424,1330.35%
Other shareholders
HAEMONETICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders